Abstract
Exercise-induced asthma can be prevented or minimized by β-adrenoreceptor stimulating drugs, which may elicit bronchodilation before exercise has begun or may enhance thebronchodilating effect of more prolonged exercise. Recently introduced β-adrenoreceptor stimulants have longer durations of action than isoproterenol, are effective following oral administration, and are selective for β-adrenoreceptors.